de Swart, L., Crouch, S., Hoeks, M., Smith, A., Langemeijer, S., Fenaux, P., Symeonidis, A., Cermâk, J., Hellström-Lindberg, E., Stauder, R., Sanz, G., Mittelman, M., Holm, M. S., Malcovati, L., Mądry, K., Germing, U., Tatic, A., Savic, A., Almeida, A. M., Gredelj-Simec, N., Guerci-Bresler, A., Beyne-Rauzy, O., Culligan, D., Kotsianidis, I., Itzykson, R., van Marrewijk, C., Blijlevens, N., Bowen, D., de Witte, T. and on behalf of the EUMDS Registry Participants (2020) “Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes”, Haematologica. Pavia, Italy, 105(3), pp. 632-639. doi: 10.3324/haematol.2018.212217.